Conversely, due to a lack of pre-existing NDV-specific antibodies and the ability of NDV to stimulate IFN-α, the NDV vector vaccines can serve as an option for immunization against important infectious diseases in mammals and humans. The gene discussed is IFNA1; the disease is infectious disease.